Condition
Pulmonary Embolism Acute Massive
Total Trials
5
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting4
Withdrawn1
Clinical Trials (5)
Showing 5 of 5 trials
NCT04855370Not ApplicableWithdrawn
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE
NCT06672081Not ApplicableRecruitingPrimary
Early Catheter-directed Treatment of High Risk Pulmonary Embolism
NCT07245927RecruitingPrimary
Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism
NCT07029841Recruiting
Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong
NCT06348459Recruiting
Registry of Catheter Intervention in Pulmonary Embolism
Showing all 5 trials